clenbuterol has been researched along with thyroxine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katsumata, M; Miyazaki, A; Yano, H | 1 |
Buyse, J; Decuypere, E; Herremans, M; Huyghebaert, G | 1 |
Chatelain, F; Martin, P; Massol, J; Puech, AJ; Soubrié, P | 1 |
Carducci, CN; Fernández Otero, GC; Lucangioli, SE; Rodríguez, VG | 1 |
Boheler, KR; Petrou, M; Wong, K; Yacoub, MH | 1 |
5 other study(ies) available for clenbuterol and thyroxine
Article | Year |
---|---|
Effect of beta agonist clenbuterol on the body composition of rats with hypothyroidism induced by oral administration of propylthiouracil.
Topics: Adipose Tissue; Animals; Body Composition; Body Weight; Cholesterol; Clenbuterol; Hypothyroidism; Liver; Male; Organ Size; Propylthiouracil; Proteins; Rats; Rats, Inbred Strains; Thyroxine; Triglycerides | 1991 |
The effect of clenbuterol supplementation on growth performance and on plasma hormone and metabolite levels of broilers.
Topics: Adipose Tissue; Analysis of Variance; Animals; Chickens; Clenbuterol; Corticosterone; Female; Glycerol; Growth Hormone; Hormones; Insulin-Like Growth Factor I; Lipids; Lipoproteins, VLDL; Male; Sex Characteristics; Thyroxine; Triglycerides; Triiodothyronine; Weight Gain | 1991 |
Impaired response of experimental diabetic mice to tricyclics: a possible beta-adrenergic mechanism.
Topics: Animals; Clenbuterol; Clomipramine; Desipramine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypothermia, Induced; Imipramine; Male; Mice; Motor Activity; Receptors, Adrenergic, beta; Thyroxine; Triiodothyronine | 1988 |
Application of extraction disks in dissolution tests of clenbuterol and levothyroxine tablets by capillary electrophoresis.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Clenbuterol; Electrophoresis, Capillary; Reproducibility of Results; Sensitivity and Specificity; Tablets; Technology, Pharmaceutical; Thyroxine | 1996 |
Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression.
Topics: Analysis of Variance; Animals; Blood Pressure; Calcium-Transporting ATPases; Cardiomegaly; Clenbuterol; Collagen; Extracellular Matrix; Heart; Male; Muscle, Skeletal; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thyroxine; Transcription, Genetic; Ventricular Function, Left | 1997 |